Data blindness
The brand sells to the channel, not the patient. It does not know who buys, how often, or at which pharmacy. Amazon and MELI already know your consumer better than you.
How WAIO works in your industryHow to add value to every product
Pharmaceutical labs · Pharma / OTC
How to add value to every product
without touching them.
WAIO differentiates your SKUs from the competition with no fixed dollar cost and only pay for results. As a consequence, it connects your laboratory with the real patient — without retail or pack.
Leading the transition from "Traditional Pharma" to "Symbiotic Pharma".
01 / The problem
Your lab sells millions.
You don't know to whom.
Three structural gaps that no marketing campaign solves:
Adherence crisis
Only 50% of chronic patients complete their treatment. Without a digital post-purchase bond, abandonment is invisible and silent for the laboratory.
Commoditization
Without a digital differentiator, any generic or competing brand wins with a 5% discount. The brand invests in R&D and loses sales on price, not quality.
02 / What changes with WAIO
What changes with WAIO
WAIO is a digital complement that turns every SKU into a symbiotic product. That Digital Complement includes a brand home and the Wellbeing Operating System that the patient receives as a gift with the purchase. The primary value: you add value to all your products without touching them and differentiate them from the competition like no one else can — with no fixed dollar cost and only pay for results.
The consequence: claim in channel; renewable access with repurchase. The home is editable white-label (branding, info, and laboratory offers) and opens a 1:1 channel. When entering the Wellbeing OS, they use the scientifically based Operating System — the apps are not editable. No retail, no pack, no registration. The product is the key. The consumer claim names the Wellbeing Operating System (the Digital Complement).
03 / How it activates
How it activates
- The patient buys the product normally at a pharmacy, supermarket, or e-commerce.
- Photographs the purchase receipt on the activation site.
- Automatic validation verifies the product (SKU), anti-fraud checks, and delivers access to the Digital Complement (Wellbeing Operating System).
- The laboratory gets a direct relationship with that consumer-patient.
No mandatory QR on pack and no IT integration with the point of sale. Compatible with fiscal receipts from chains and pharmacies.
04 / Channels
One simple message across
all channels.
The laboratory communicates the benefit across multiple channels. The consumer claim names the Wellbeing Operating System (the Digital Complement). The patient buys normally and activates with the receipt. Nothing required from retail.
Doctor / Medical rep
Clinic & ethical line
Designed to empower the medical rep in their 3-minute visit. Delivers a “digital free sample” that explains itself. The doctor gifts value without consuming time; the patient must buy the brand to activate. In PSP: direct code to the enrolled patient (e.g. 12 months).
Pharmacy
Counter & point of sale
The pharmacy attendant is the commercial star: offers profitability and loyalty. POP communicates with zero employee burden. Co-branded lab/pharmacy experience and local repurchase via WhatsApp.
OTC / mass
Supermarket & e-commerce
Stopper or product page communicate the claim. Zero chain coordination. “Activate 30 days of the Wellbeing Operating System” is worth $15–$20 USD perceived — differentiation without discount.
Digital channels (no printing or production spend)
Digital channels are the most efficient way to communicate the benefit: no print materials, the validator link is one click away, and the laboratory can update the message in real time.
E-commerce
Claim on product page. No printing. No marketplace coordination. Stackable: 2 purchases = 2× duration.
Social networks
Story, reel, or post communicate the benefit. The network is awareness; the Wellbeing Operating System is the close when buying and activating.
Existing CRM
HCPs, prior program patients, or subscribers receive the benefit by email or WhatsApp.
05 / Flexibility
The laboratory chooses
duration and objective.
OTC / mass
Short term (e.g. 30 days). Expired access is the best repurchase call-to-action.
Chronics
Medium term (e.g. 90 days), stackable per purchase. Adherence measured in real time.
PSP
Long term (e.g. 12 months). Direct code to the enrolled patient: accompany and measure.
Premium
Extended term (e.g. 6 months). Justifies premium price against generics.
06 / What you gain
The detail of what you gain
with each activation.
Differentiation
Perceived-value claim against generics and the price war.
Sales and margin increase
Channel conversion through value, not only discount.
Integral Organic Retention
Access renews with physical product repurchase — through continuous value, not commercial pressure.
Your own data
Email, WhatsApp, purchase channel, and frequency. The base belongs to the laboratory, not retail.
Direct channel
1:1 post-purchase relationship via the brand home (news / messages you define) — without depending on retail.
Adherence and usage evidence
Real usage data available according to each implementation agreement.
Empowered sales force
Medical reps and pharmacy attendants with a differential asset in visits and at the counter.
Symbiotic product
Without touching registration, packaging, or retail IT. Ready in days.
07 / Commercial model
Zero risk.
Pay only if it works.
USD 0.50 per successful activation
No setup. No fixed license. If they bought and did not activate: the laboratory won the sale and does not pay. The channel claim can still improve conversion. Ready to launch in less than a week. Scalable across the full portfolio without touching a single product.
Without activation
The laboratory won the sale and paid nothing to WAIO.
With activation
For USD 0.50: your own data, direct channel, and retention. Example: $10 product → $10 repurchase = strong ROI vs. activation cost.
| Metric | Meta / Google Ads | WAIO |
|---|---|---|
| Cost per identified user | USD 15 — 55 | USD 0.50 |
| Consumer relationship | Anonymous / intermediated | Direct — your own data |
08 / Endorsements
Triple
institutional validation.
CONICET (RITS)
Letter of intent to research the impact of WAIO's AI on healthcare cost reduction. Scientific backing for the research and integration line.
Dr. Pedro de Elizalde Children's Hospital
Clinical research protocol RCT 17771 approved by the Ethics Committee (~2,000 participants). Ethical and clinical rigor.
ITBA
Model under the framework of a PhD in Systemic Innovation. Academic support for the architecture and system innovation.
10 / Free micro-pilot
Try first.
Let the evidence speak.
Free digital micro-pilot of 2–4 weeks. No pack, no retail, no IT integration, and no long committee: one SKU, one digital channel you already control, and a small A/B test. Group A: usual message / purchase. Group B: same SKU + Wellbeing Operating System claim (receipt activation). Typical channel: CRM base, patient program, or email to HCPs who already recommend the product. What you watch: activations, repurchase in the window, and intent to renew access. Suggested cap: 200–500 activations. In a few weeks you have your own evidence — without a prior strategic decision. Zero cost. Zero friction. If it works, you scale; if not, you lost nothing.
Reduces perceived risk for Legal, Compliance, and leadership: scientific backing, ethical rigor, and architecture ready for due diligence. WAIO is live, scientifically validated, and coordinating pilots with leading laboratories. Implement WAIO on your brands with zero commercial risk — or request the free micro-pilot.
Next step